These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24767340)

  • 1. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
    Uemoto S; Abe R; Horike H; So M
    Transplant Proc; 2014 Apr; 46(3):749-53. PubMed ID: 24767340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan.
    Takahashi K; Abe R; Usuki S; So M
    Transplant Proc; 2014; 46(2):406-10. PubMed ID: 24655975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Effectiveness of Once-Daily, Prolonged-Release Tacrolimus in De Novo Kidney Transplant Recipients: 5-year, Multicenter Postmarketing Surveillance in Japan.
    Wakasugi N; Uchida H; Uno S
    Transplant Proc; 2018 Dec; 50(10):3296-3305. PubMed ID: 30577199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
    Dumortier J; Guillaud O; Boillot O
    Liver Transpl; 2013 May; 19(5):529-33. PubMed ID: 23483701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
    Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
    Kim SH; Lee SD; Kim YK; Park SJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
    Florman S; Alloway R; Kalayoglu M; Punch J; Bak T; Melancon J; Klintmalm G; Busque S; Charlton M; Lake J; Dhadda S; Wisemandle K; Wirth M; Fitzsimmons W; Holman J; First MR
    Transplantation; 2007 Jun; 83(12):1639-42. PubMed ID: 17589349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience.
    Slatinska J; Rohal T; Wohlfahrtova M; Viklicky O
    Transplant Proc; 2013 May; 45(4):1491-6. PubMed ID: 23726604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
    Coilly A; Calmus Y; Chermak F; Dumortier J; Duvoux C; Guillaud O; Houssel-Debry P; Neau-Cransac M; Stocco J
    Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
    Bäckman L; Persson CA
    Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study.
    Dopazo C; Rodriguez R; Llado L; Calatayud D; Castells L; Ramos E; Molina V; García R; Fabregat J; Charco R
    Clin Transplant; 2012; 26(1):E32-7. PubMed ID: 21958123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
    McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
    Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily prolonged-release tacrolimus in de novo liver transplantation: a single center cohort study.
    Marubashi S; Wada H; Kobayashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Hepatogastroenterology; 2012 Jun; 59(116):1184-8. PubMed ID: 22172333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
    Kolonko A; Chudek J; Wiecek A
    Transplant Proc; 2011 Oct; 43(8):2950-3. PubMed ID: 21996198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients.
    Uchida J; Iwai T; Kabei K; Machida Y; Kuwabara N; Naganuma T; Kumada N; Nakatani T
    Transplant Proc; 2014; 46(2):532-6. PubMed ID: 24656005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up.
    Giannelli V; Rossi M; Giusto M; Lucidi C; Lattanzi B; Ruffa A; Ginanni Corradini S; Mennini G; Melandro F; Lai Q; Berloco P; Merli M
    Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2718-20. PubMed ID: 24174352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study.
    Lee EC; Kim SH; Park SJ
    Ann Transplant; 2018 Oct; 23():713-720. PubMed ID: 30310047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.